Tag:
Lipitor
Latest Headlines
Latest Headlines
Insurers shift prescription costs to members with drug tiers
Insurers increasingly are altering their benefit structures to shift the cost of many expensive medications onto their chronically ill members. This "insidious trend" is causing health insurance
WellPoint drops Lipitor coverage
WellPoint will stop covering the cholesterol-lowering drug, Lipitor, and instead pay for generic versions beginning April 1. The insurer hopes the coverage change will compel members to take the
UnitedHealth, Coventry scrutinized for favoring brand-name drug
UnitedHealthcare and Coventry are being investigated for their role in Pfizer's attempt to block new generic competition in favor of its cholesterol-lowering drug Lipitor. Since Lipitor lost its
UnitedHealth to price Lipitor cheaper than generics
UnitedHealthcare will encourage its members to continue using Pfizer's cholesterol-lowering drug Lipitor instead of the generic version after Lipitor loses patent protection at the end of the month.
Lowering co-pays improves medication adherence
Insurance plans that reduced or eliminated co-payments for medications have seen an increase in the number of people following their prescriptions, according to two studies published in Health
Drugmaker rebates short-circuit impact of health plan co-pays
In theory, the co-pay system is supposed to encourage smart shopping without sacrificing patients' health. Patients pay higher portions of the bill--sometimes more than double--for pricier branded
Study: Even small gifts influence doctors
When professionals talk about the influence of pharma or medical device gifts on doctors, most are discussing consulting fees, vacations disguised as CME classes and the like, not pens or sticky
Cigna lowers copay on cholesterol drug Lipitor
In recent times, we've been telling you that patients are not only avoiding elective procedures, but sometimes skipping prescribed medications to save money; apparently health insurer Cigna has been
Drugmakers agree to six-month DTC delay
Under fire over direct-to-consumer ads, which some Congressional legislators contend are misleading to consumers, pharmaceutical companies have agreed to voluntarily wait six months after drugs are
Drugmakers agree to six-month DTC delay
Under fire over direct-to-consumer ads, which some Congressional legislators contend are misleading to consumers, pharmaceutical companies have agreed to voluntarily wait six months after drugs are
